Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Joint Metastasis Research Society-AACR Conference on Metastasis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 15, 617-619, October 1, 1955]
© 1955 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trams, E. G.
Right arrow Articles by Klopp, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trams, E. G.
Right arrow Articles by Klopp, C. T.

Distribution of Radiocarbon in Liver Choline, Creatine, and Methionine after the Injection of Methyl-C14-bis(ß-chloroethyl)amine*

Eberhard G. Trams{dagger} and Calvin T. Klopp

( George Washington University Cancer Clinic, Washington, D.C.)

Male adult rats were injected intravenously with methyl-C14-bis(ß-chloroethyl)amine HCl (HN2) over periods of 1–4 days. The amount of C14 contained in choline, creatine, and the S-methyl group of methionine isolated from the livers of these animals was determined. While the S-methyl group of methionine and creatine showed little, if any, incorporation of C14, 0.12–0.41 per cent of the total injected radioactivity was recovered in choline. Although incorporation of the labeled N-methyl group of HN2 into choline was demonstrated, it was concluded that transmethylation reactions do not represent major pathways in the intermediary metabolism of HN2.

* This investigation was supported in part by a grant-inaid from the National Cancer Institute and by an Institutional Grant from the American Cancer Society.

{dagger} Present address: Department of Pharmacology, George Washington University, School of Medicine, Washington, D.C.

Received 5/18/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1955 by the American Association for Cancer Research.